Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study

Annals of Neurology

Volumn 41, Issue 2, 1997, Pages 222-229

  Piccini, P ^a   Morrish, P K ^a   Turjanski, N ^a   Sawle, G V ^a   Burn, D J ^a   Weeks, R A ^a   Mark, M H ^b   Maraganore, D M ^c   Lees, A J ^d   Brooks, D J ^d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b New Jersey Robert Wood Johnson M S   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; HUMAN; INHERITANCE; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; BRAIN; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031049889     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410213     Document Type: Article

References (51)

1. Degl'Innocenti F, Maurello MR, Marini P. A parkinsonian kindred. Ital J Neurol Sci 1989;10:307-310
2. Golbe LI, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27: 276-282
3. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 1994;35: 59-64
4. Wszolek ZK, Pfeiffer B, Fulgham JR, et al. Western Nebraska family (Family D) with autosomal dominant Parkinson's disease. Ann Neurol 1993;34:264
5. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995;38:373-378
6. Duvoisin RC. The genetics of Parkinson's disease: a review. In: Rinne UK, Nagatsu T, Horowski R, eds. International Workshop, Berlin, Parkinson's Disease. Netherlands: Medicom, 1991;38-57
7. Golbe LI, Di Iorio G, Lazzarini AM, et al. A large kindred with Parkinson's disease: onset age, segregation ratios and anticipation. Mov Disord 1993;8:406
8. Bonifati V, Vanacore N, Meco G. Anticipation of onset age in familial Parkinson's disease. Neurology 1994;44:1978-1979
9. Payami H, Bernard S, Larsen K, et al. Genetic anticipation in Parkinson's disease. Neurology 1995;45:135-138
10. Duvoisin RC. Recent advances in the genetics of Parkinson's disease. Adv Neurol 1996;69:33-40
11. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer disease: comparison of risk among relatives of early- and late-onset and among male and female relatives in successive generations. Neurology 1988;38:207-212
12. Forno LS, Alvord EC. The pathology of parkinsonism. Part I. Some new observations and correlations. In: McDowell F, Markham C, eds. Recent advances in Parkinson's disease. Philadelphia: FA Davis, 1971:120-130
13. Gibb WRG. Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 1986;12:223-234
14. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845
15. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752
16. Nahamias C, Garnett ES, Firnau G, Lang A. Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci 1985;69:223-230
17. 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990;28: 547-555
18. Martin WRW, Plamer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989;26:535-542
19. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic anatomy of Parkinson's: complementary 18F-fluorodeoxyglucose and 18F-fluorodopa positron emission tomographic studies. Mov Disord 1990;5:203-213
20. Otsuka M, Ichiya Y, Hosokawa S, et al. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 1991;54:898-904
21. 18F-dopa and positron emission tomography. Neurology 1992;42:1894-1900
22. Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994; 36:176-182
23. 18F-dopa positron emission tomography studies in an Irish kindred. Ann Neurol 1992;32:609-617
24. Spinks TJ, Jones T, Gilardi MC, Heather JD. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Med 1988;35:721-725
25. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. New York: Georg Thieme, 1988
26. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584-590
27. Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure and Parkinson's disease, studied with PET. Brain 1990;113:1539-1552
28. 18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography. Acta Neurol Scand 1990;81:24-30
29. Gjedde A, Reith J, Dyve S, et al. Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci USA 1991;88: 2721-2725
30. Calne DB, Langston JW, Martin WRW, et al. Positron emission tomography after MPTP. Observation relating to the cause of Parkinson's disease. Nature 1985;317:246-248
31. Snow BJ, Martin WR, Calne DB. A case of subclinical idiopathic parkinsonism detected with fluorodopa PET. Presented at the 10th International Symposium on Parkinson's Disease, Tokyo, Japan, October 27, 1991
32. Todes CJ, Lees AJ. The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985;48: 97-100
33. Calne DB, Eisen A, McGeer EG, Spencer P. Alzheimer disease, Parkinson's disease and motoneurone disease: abiotrophic interaction between aging and environment. Lancet 1986;(1): 1067-1070
34. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: sub- stantia nigra regional selectivity. Brain 1991;114:2283-2301
35. 18F-dopa-PET and clinical study of the rate of the progression in Parkinson's disease. Brain 1996;119:585-591
36. Koller WC. When does Parkinson's disease begin? Neurology 1992;42(suppl 4):27-31
37. Vingerhoets FJG, Snow BJ, Lees CS, et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic Parkinson's disease. Ann Neurol 1994;36:759-764
38. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
39. Langston JW, Koller WC. The next frontier in Parkinson's disease: presymptomatic detection. Neurology 1991;41(suppl 2):5-7
40. 2 dopamine receptors in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 1996;40:49-54
41. Golbe LI. The genetics of Parkinson's disease: a reconsideration. Neurology 1990;40(suppl 3):7-14
42. Semchuck KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43: 1173-1180
43. Bonifati V, Fabrizio E, Vanacore N, et al. Familial Parkinson's disease. A clinical genetic analysis. Can J Neurol Sci 1995;22: 272-279
44. Mjones SH. Paralysis agitans: a clinical and genetic study. Acta Psychiatr Neurol Scand 1949;25(suppl 54):1-95
45. Maraganore DM, Harding AE, Marsden CD. A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991; 6:205-211
46. Lazzarini AM, Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506
47. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661
48. Golbe LI, Lazzarini AM, Schawarz KO, et al. Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 1993;43:2222-2227
49. Mauri JA, Asensio M, Jimenez A, et al. Enfermedad de Parkinson familiar. Neurologia 1990;42:45-47
50. Duvoisin RC, Golbe LI. Kindreds of dominantly inherited Parkinson's disease: keys to the riddle. Ann Neurol 1995;38:355-356
51. Carrero-Venezuela R, Lindblad K, Payami H, et al. No evidence for association of familial Parkinson's disease with CAG repeat expansion. Neurology 1995;45:1760-1763